Research programme: monoclonal antibodies and small molecule therapeutics - MediaPharma

Drug Profile

Research programme: monoclonal antibodies and small molecule therapeutics - MediaPharma

Alternative Names: mab EV20; MP BF 001; MP-1959 (SP-2); MP-3546; MP-AA-1; MP-E-8-3/1959; MP-E-8.3; MP-EV-20; MP-EV20-DC54; MP-EV20-RT; MP-HE-001A; MP-HE-001B; MP-HE-001C; MP-PN-1; MP-PN-2; MP-RM-1 (ErbB-3 antibody)

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator MediaPharma
  • Class Drug conjugates; Immunoconjugates; Monoclonal antibodies; Small molecules
  • Mechanism of Action Carrier protein inhibitors; CD248 antigen inhibitors; Epidermal growth factor receptor modulators; ERBB-3 receptor antagonists; Hypoxia-inducible factor 1 inhibitors; Hypoxia-inducible factor-1 alpha inhibitors; Receptor protein-tyrosine kinase modulators; Transcriptional elongation factor inhibitors; Transcriptional elongation factor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Diabetic foot ulcer; Pancreatic cancer; Phaeochromocytoma; Renal cell carcinoma; Stroke; Von Hippel-Lindau disease
  • No development reported Cancer

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in Italy
  • 01 Apr 2017 Pharmacodynamics data from preclinical studies in Cancer presented at the 108th Annual Meeting of the American Association for Cancer Research (AACR-2017)
  • 08 Sep 2016 Preclinical trials in Pancreatic cancer in Italy (unspecified route) before September 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top